Change - Announcement of Appointment::Appointment of Executive Director and Chief Executive Officer

Issuer & Securities

Issuer/ Manager
17LIVE GROUP LIMITED
Securities
17LIVE GROUP LIMITED - KYG9481M1298 - VT1
17LIVE GROUP LIMITED W281207 - KYG9481M1116 - VT2W
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
08-Dec-2023 07:07:24
Status
New
Announcement Sub Title
Appointment of Executive Director and Chief Executive Officer
Announcement Reference
SG231208OTHRD2WS
Submitted By (Co./ Ind. Name)
Eunice Hooi
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Executive Director and Chief Executive Officer in connection with the business combination between Vertex Technology Acquisition Corporation Ltd. and 17LIVE Inc..

DBS Bank Ltd. acted as the sole issue manager for the business combination of Vertex Technology Acquisition Corporation Ltd. with 17LIVE Inc..

Additional Details

Date Of Appointment
07/12/2023
Name Of Person
Lien Chien-Lin
Age
51
Country Of Principal Residence
Taiwan, Province Of China
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
Upon the recommendation of the Nominating Committee which had reviewed the qualifications and experience of Lien Chien-Lin as set out below, the Board of Directors has approved the appointment of Lien Chien-Lin as Executive Director and Chief Executive Officer of the Company.


The appointment has also been approved by shareholders at the Extraordinary General Meeting held on 1 December 2023.
Whether appointment is executive, and if so, the area of responsibility
The appointment is executive, and Mr. Lien shall be responsible for the Group's overall operations and strategic direction.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Executive Officer
Professional qualifications
No
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
Mr. Lien has served as the 17LIVE Inc.'s ("Target Company") CEO since March 2023. Mr. Lien joined the Target Company in September 2019 as the general manager of Taiwan Operations. He was promoted to CEO of Taiwan, Southeast Asia, U.S. operations in January 2021 and to global chief operating officer in August 2022 before he was appointed as the Target Company's global CEO.

Mr. Lien has held management positions in various Fortune 500 companies including Starbucks Coffee Company with hands-on experience in global operations, and has extensive experience in the gaming industry accumulated from his tenure at various gaming companies, including Electronic Arts. Prior to joining the Target Company, Mr. Lien served as the chief operating officer of a mobile game start-up in Shanghai focusing on narrative and user-generated content.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Yes. Mr. Lien will hold 1,167,728 ordinary shares in the capital of the listed issuer post-completion of the business combination between Vertex Technology Acquisition Corporation Ltd. and 17LIVE Inc..
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
- Ichi Nana Inc.
- Next Entertainment Global Holding
- Next Entertainment Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Mr Lien will be attending training on the roles and responsibilities of a listed issuer as prescribed by the Exchange.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable